Diary - News All news BioSerenity, digital health champion, raises 15 million Euros

BioSerenity, digital health champion, raises 15 million Euros

Paris, September 20th 2017 - Start-up specialized in connected solutions for patients, BioSerenity closed a Series A round of €15 million led by LBO France and investments from Idinvest Partners and PSIM fund managed by Bpifrance.

BioSerenity has developed several product lines to facilitate the diagnosis and monitoring of patients. The high growth medtech company collaborated with several large scale university hospitals across the globe and plans on leveraging the new round of financing to continue its industrialization, and internationalization. With over 80 employees, BioSerenity has recently opened new offices in France, China and the United-States.

Read the press release

Headlines

Our members

Synthelis presents its article related to a vaccine candidate against nosocomial infections caused by Pseudomonas aeruginosa

October 28^th, 2021

NH TherAguix announces the release of a new clinical batch for its drug AGuIX, manufactured by CARBOGEN AMCIS

November 4^th, 2021

Novadiscovery Continues Global Expansion with the Launch of its US Headquarters in Boston, MA

November 2^nd, 2021

All news